Alethea Capital Management, LLC Axsome Therapeutics, Inc. Transaction History

Alethea Capital Management, LLC

$138 Million
Q3 2024

A detailed history of Alethea Capital Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Alethea Capital Management, LLC holds 738,503 shares of AXSM stock, worth $67 Million. This represents 48.23% of its overall portfolio holdings.

Number of Shares

738,503

Previous 740,888 0.32%

Holding current value

$67 Million

Previous $59.6 Million 11.26%

% of portfolio

48.23%

Previous 45.59%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $188,248 - $228,578	-2,385 Reduced 0.32%	738,503 $66.4 Million
Q2 2024 Aug 15, 2024	BUY	$65.72 - $80.5 $6,374 - $7,808	97 Added 0.01%	740,888 $59.6 Million
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $780,845 - $1.1 Million	-11,253 Reduced 1.5%	740,791 $59.1 Million
Q4 2023 Feb 14, 2024	SELL	$57.42 - $83.61 $387,585 - $564,367	-6,750 Reduced 0.89%	752,044 $59.9 Million
Q3 2023 Nov 14, 2023	SELL	$69.25 - $82.21 $79,637 - $94,541	-1,150 Reduced 0.15%	758,794 $53 Million
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $1.5 Million - $2.33 Million	-25,739 Reduced 3.28%	759,944 $54.6 Million
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $103,045 - $205,677	-2,580 Reduced 0.33%	785,683 $60.6 Million
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $55,893 - $108,267	-1,550 Reduced 0.2%	788,263 $35.2 Million
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $5.51 Million - $11.8 Million	-253,346 Reduced 24.29%	789,813 $30.3 Million
Q1 2022 May 13, 2022	SELL	$23.7 - $41.39 $1.91 Million - $3.34 Million	-80,770 Reduced 7.19%	1,043,159 $43.2 Million
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $267,581 - $377,925	-8,716 Reduced 0.77%	1,123,929 $42.5 Million
Q3 2021 Oct 27, 2021	BUY	$19.91 - $68.26 $2.42 Million - $8.31 Million	121,700 Added 12.04%	1,132,645 $37.3 Million
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $63,692 - $92,463	-1,258 Reduced 0.12%	1,010,945 $68.2 Million
Q1 2021 May 14, 2021	BUY	$55.91 - $81.44 $134,407 - $195,781	2,404 Added 0.24%	1,012,203 $57.3 Million
Q4 2020 Feb 12, 2021	BUY	$66.31 - $86.52 $44,295 - $57,795	668 Added 0.07%	1,009,799 $82.3 Million
Q3 2020 Nov 16, 2020	BUY	$68.34 - $85.84 $42,575 - $53,478	623 Added 0.06%	1,009,131 $71.9 Million
Q2 2020 Aug 11, 2020	BUY	$49.87 - $98.69 $835,521 - $1.65 Million	16,754 Added 1.69%	1,008,508 $83 Million
Q1 2020 May 11, 2020	SELL	$41.2 - $101.31 $363,631 - $894,162	-8,826 Reduced 0.88%	991,754 $58.3 Million
Q4 2019 Feb 10, 2020	SELL	$16.71 - $106.24 $5.04 Million - $32.1 Million	-301,766 Reduced 23.17%	1,000,580 $103 Million
Q2 2019 Aug 12, 2019	BUY	$13.46 - $25.75 $2.18 Million - $4.17 Million	161,952 Added 14.2%	1,302,346 $33.5 Million
Q1 2019 May 06, 2019	BUY	$2.63 - $16.34 $610,067 - $3.79 Million	231,965 Added 25.53%	1,140,394 $16.2 Million
Q4 2018 Jan 23, 2019	BUY	$2.0 - $4.15 $721,972 - $1.5 Million	360,986 Added 65.94%	908,429 $2.56 Million
Q3 2018 Oct 29, 2018	BUY	$2.3 - $3.55 $636,226 - $982,001	276,620 Added 102.14%	547,443 $1.89 Million
Q2 2018 Jul 17, 2018	BUY	$2.15 - $3.6 $331,794 - $555,562	154,323 Added 132.47%	270,823 $867,000
Q4 2017 Feb 14, 2018	BUY	$4.45 - $6.2 $518,425 - $722,300	116,500	116,500 $652,000

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alethea Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alethea Capital Management, LLC with notifications on news.

Account

Alethea Capital Management, LLC Axsome Therapeutics, Inc. Transaction History